Argenica strengthens the clinical case for neuroprotective drug candidate ARG-007 with new independently generated ...

Imperative Care announced new real-world data evaluating ADAPT 2.0, a next-generation approach to stroke treatment.

A new meta-analysis of 31 preclinical studies suggests GLP-1 drugs like semaglutide may reduce ischemic stroke severity in ...

Imperative Care, Inc. today announced the presentation of late-breaking, real-world data from a multi-center review of ischemic stroke patients treated with ADAPT 2.0, a next-generation approach to A ...

Ischemic stroke, a leading cause of disability and mortality worldwide, is a complex cerebrovascular event with outcomes ...

Systematic review suggests GLP-1 receptor agonists offer strong preclinical neuroprotection in nondiabetic ischemic stroke, ...

Prasugrel may be the P2Y12 inhibitor of choice for use in combination with aspirin after PCI in patients with diabetes and ...

Ischemic stroke is a complex cerebrovascular disorder characterized by highly unpredictable outcomes influenced by ...

Infections, including influenza, COVID-19, HIV, hepatitis C and herpes zoster, can raise the risk of cardiovascular disease (CVD), and vaccines could help lower that risk, according to a study ...

Researchers at University Medical Center Maastricht and international partners report that a single shot of the drug ...

A low dose of colchicine — a commonly used gout drug — helped reduce the risk of heart attack and stroke in people with ...

HealthDay News — There is a bidirectional association between myocardial infarction (MI) and late-onset epilepsy (LOE), according to a study published online Nov. 5 in Neurology.